Findings aid antiviral drug discovery
Many viral infections, such as the common cold, cause mild illnesses that the body’s immune system eventually defeats. But when viruses cause severe disease, doctors have few options for effective treatment.
Studying mice with a variety of viral infections, scientists at Washington University School of Medicine in St. Louis have demonstrated a way to dial up the body’s innate immune defenses while simultaneously attacking a protein that many viruses rely on to replicate.
The findings, published Oct. 19 in Nature Immunology, reveal previously unknown weapons in the body’s antiviral immune arsenal and provide guidelines for designing drugs that could be effective against a broad range of viruses. The strategy involves enhancing the body’s interferon signaling system, long understood to be a vital part of antiviral defenses.
“We’ve discovered a new component of the interferon system,” said senior author Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of Medicine. “It does something that other components don’t do, and it works on both sides of the fence: It dials up the body’s internal genes that fight viruses, and it attacks viral proteins directly.”
Holtzman and lead author Yong Zhang, PhD, an instructor in pulmonary medicine, suspect that the researchers’ one-two punch against the virus may explain the large difference in survival rates between control mice and mice genetically engineered to have increased signaling in their interferon systems.
When infected with encephalomyocarditis virus, which causes severe damage to vital organs including the brain, heart and pancreas, 97 percent of the genetically engineered mice survived, compared with none of the control mice. Even when the concentration of the injected virus was increased 100-fold, 82 percent of the genetically altered mice survived. And at 100-fold lower concentrations, all genetically engineered mice survived the infection, compared with only 25-28 percent of the control mice.
Holtzman pointed out that past research by other groups has shown that increasing the amount of interferon directly results in some improvements in fighting viruses, but not to the same extent as the current work. In addition, more modest improvements shown by other investigators usually are accompanied by autoimmune problems resulting from the chronically activated immune response. Despite the strong antiviral immune response seen in the new study, Holtzman and his colleagues reported no evidence of autoimmune disease in these mice.
The Latest on: Antiviral immune response
via Google News
The Latest on: Antiviral immune response
- Bats, pangolins and viral Lego: curious clues of the new coronaviruson April 7, 2020 at 9:48 am
“Instead we need to look at why they don’t get sick.” Their research in other bat species has shown that bats can mount a rapid immune response against viruses and then, crucially, switch that ...
- Test vaccine elicits strong response to SARS-CoV-2 in miceon April 6, 2020 at 7:43 am
Codon-optimized MERS-S1 subunit vaccines fused with a foldon trimerization domain were generated to mimic the native viral structure. Immune stimulants were engineered into this trimeric ... by MNA ...
- Companies Seek New Methods to Fight Viral Infectionson April 6, 2020 at 6:00 am
Infectious diseases such as Ebola, Influenza, Zika, MERS and the recent pandemic that is still spreading, cause enormous loss of life ...
- Molecular bases for HOIPINs-mediated inhibition of LUBAC and innate immune responseson April 4, 2020 at 10:28 pm
Daisuke Oikawa et al. provide structural insights into how small-molecule inhibitors of LUBAC ubiquitin ligase, HOIPINs, bind to LUBAC. They find that HOIPINs trigger apoptosis in lymphoma cells and ...
- Coronavirus: The Importance of Viral Loadon April 3, 2020 at 6:46 am
Much of COVID-19’s prevalence, severity, and lethality may have to do with viral particles you are exposed to – the issue of viral load, also called viral dose. Not much is written on this subject ...
- Explainer: What is a viral load and does it impact on the severity of Covid-19 symptoms?on April 2, 2020 at 11:15 pm
Concerns were raised on social media in relation to the viral load that would be contracted by healthcare workers.
- Fucoidan: The Immune Health and Antiviral Propertieson April 2, 2020 at 8:40 pm
At a time when global interest in immune health is at an unprecedented high, consumers around the world are turning attention to ...
- Phage capsid against influenza: Perfectly fitting inhibitor prevents viral infectionon April 2, 2020 at 1:08 pm
Current antiviral drugs are only partially effective because they attack the influenza ... It is not yet known, for example, whether the phage capsid provokes an immune response in mammals. Ideally, ...
- A durable protective immune response to wild-type measles virus infection of macaques is due to viral replication and spread in lymphoid tissueson April 1, 2020 at 11:13 am
studied virus replication and immune responses in infected rhesus macaques. Both WT MeV and LAMV replicated well in respiratory epithelial cells. However, although WT MeV replicated well in ...
- Cells’ Response to SARS-CoV-2 Different from Flu, RSVon April 1, 2020 at 10:39 am
When they looked at which genes were upregulated in response to viral infection, they found that SARS-CoV-2 spurred the expression ... people seem to have more severe disease after SARS-CoV-2 ...
via Bing News